Status:
COMPLETED
Treatment Response in Schizophrenia: Bridging Imaging and Postmortem Studies
Lead Sponsor:
University of Alabama at Birmingham
Conditions:
Schizophrenia
Eligibility:
All Genders
19-55 years
Brief Summary
The overarching goal is to identify imaging markers that will predict treatment response, and to confirm or validate these biomarkers using anatomical studies of postmortem tissue. Early detection of ...
Detailed Description
Our past brain imaging and Positron Emission Tomography (PET) studies have contributed to the understanding of specific brain regions related to treatment response to antipsychotic drugs in schizophre...
Eligibility Criteria
Inclusion
- Normal volunteers or schizophrenic patients between the age of 19 and 55.
Exclusion
- Individuals with a diagnosable central nervous system illness.
- Major medical condition, active substance abuse or dependence, pregnancy, or history of head trauma.
Key Trial Info
Start Date :
October 1 2008
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
June 30 2021
Estimated Enrollment :
75 Patients enrolled
Trial Details
Trial ID
NCT00937716
Start Date
October 1 2008
End Date
June 30 2021
Last Update
July 26 2021
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
University of Alabama at Birmingham, Department of Psychiatry, SC 501
Birmingham, Alabama, United States, 35294